There's No Escaping Metagenomi, Inc.'s (NASDAQ:MGX) Muted Revenues Despite A 89% Share Price Rise

Simply Wall StDec 13 02:30

Wells Fargo Maintains Metagenomi Technologies, LLC(MGX.US) With Buy Rating, Maintains Target Price $25

Futu NewsDec 12 20:31 · Ratings

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference "RNA at the Bench and Bedside IV"

GlobeNewswireDec 12 07:30

Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts

BenzingaDec 10 23:00

Metagenomi Shares Halted On Circuit Breaker To The Upside, Stock Now Up 11.8%

BenzingaDec 10 22:31

Metagenomi Is Maintained at Buy by HC Wainwright & Co.

Dow JonesDec 10 20:51 · Ratings